Fragile-X–Associated Tremor/Ataxia Syndrome (FXTAS) in Females with the FMR1 Premutation-Reference-Cited by-同舟云学术

Fragile-X–Associated Tremor/Ataxia Syndrome (FXTAS) in Females with the FMR1 Premutation

Published:2004-05 Issue:5 Volume:74 Page:1051-1056
ISSN:0002-9297
Container-title:The American Journal of Human Genetics
language:en
Short-container-title:The American Journal of Human Genetics

Author:

Hagerman R.J.,Leavitt B.R.,Farzin F.,Jacquemont S.,Greco C.M.,Brunberg J.A.,Tassone F.,Hessl D.,Harris S.W.,Zhang L.,Jardini T.,Gane L.W.,Ferranti J.,Ruiz L.,Leehey M.A.,Grigsby J.,Hagerman P.J.

Publisher

Elsevier BV

Subject

Genetics(clinical),Genetics

Reference25 articles.

1. Fragile X premutation is a significant risk factor for premature ovarian failure: the international collaborative POF in fragile X study—preliminary data;Allingham-Hawkins;Am J Med Genet,1999

2. Tremor and ataxia in fragile X premutation carriers: blinded videotape study;Berry-Kravis;Ann Neurol,2003

3. Fragile X premutation carriers: characteristic MR imaging findings in adult males with progressive cerebellar and cognitive dysfunction;Brunberg;Am J Neuroradiol,2002

4. Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1;Franke;Psychiatry Res,1998

5. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers;Greco;Brain,2002

Cited by 277 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sensorimotor and inhibitory control in aging FMR1 premutation carriers;Frontiers in Human Neuroscience;2023-11-16

2. Evaluating the clinical utility of a long-read sequencing-based approach in genetic testing of fragile-X syndrome;Clinica Chimica Acta;2023-11

3. Incidental molecular diagnoses and heterozygous risk alleles in a carrier screening cohort;Genetics in Medicine;2023-02

4. Premature Ovarian Failure;Managing Psychosexual Consequences in Chronic Diseases;2023

5. Artificial neural network applied to fragile X-associated tremor/ataxia syndrome stage diagnosis based on peripheral mitochondrial bioenergetics and brain imaging outcomes;Scientific Reports;2022-12-10